🇺🇸 FDA
Patent

US 10633643

Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells

granted A61KA61K38/45A61K47/6415

Quick answer

US patent 10633643 (Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/45, A61K47/6415, A61K49/0056, A61P